(Press-News.org) ROCHESTER, Minn. -- The investigational drug ixazomib taken orally in combination with lenalidomide and dexamethasone shows promise in patients with newly diagnosed multiple myeloma, according to the results of a phase 1/2 study published in the journal Lancet Oncology.
"Ixazomib is an investigational, oral proteasome inhibitor with promising anti-myeloma effects and low rates of peripheral neuropathy," says Shaji Kumar, M.D., a hematologist at Mayo Clinic and lead author of the study. "While it is well known that a combination of bortezomib, lenalidomide and dexamethasone is highly effective in treating newly diagnosed multiple myeloma, we wanted to study the safety, tolerability and activity of ixazomib in combination with lenalidomide and dexamethasone in newly diagnosed multiple myeloma."
Dr. Kumar and colleagues enrolled 65 patients (15 to phase 1 and 50 to phase 2) between November 2010 and February 2012. Researchers established 2.97 mg/m2 as the maximum tolerated dose of ixazomib and recommended the phase 2 dose should be 2.23 mg/m2, which was converted to a 4.0 mg fixed dose based on population pharmacokinetic results. Population pharmacokinetics is the study of the sources of variability in drug concentrations among patients receiving the drug based on demographics, body weight, metabolism and other medications.
There were 41 grade 3 or higher adverse events reported, including skin and subcutaneous tissue disorders neutropenia and thrombocytopenia and drug-related peripheral neuropathy. Five patients discontinued therapy because of adverse events. In 64 response-evaluable patients, 59 (92 percent) had a partial response, including 37 who had a very good partial response or better.
Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon (grey), oxygen (red), nitrogen (blue)."The all-oral combination of weekly ixazomib plus lenalidomide and dexamethasone was generally well tolerated and appeared active in patients with newly diagnosed multiple myeloma," Dr. Kumar says. "Our results support the development of a phase 3 trial studying this combination for multiple myeloma."
INFORMATION:
Co-authors include Vincent Rajkumar, M.D., Keith Stewart, M.B., Ch.B., and Vivek Roy, M.D., of Mayo Clinic; Jesus Berdeja, M.D., Sarah Cannon Research Institute; Ruben Niesvizky, M.D., Weill Cornell Medical College; Paul Richardson, M.D., and Jacob Laubach, M.D., of Dana-Farber Cancer Institute; Mehdi Hamadani, M.D., Mary Babb Randolph Cancer Center; Parameswaran Hari, M.D., Medical College of Wisconsin; Robert Vescio, M.D., Samuel Oschin Comprehensive Cancer Institute; Sagar Lonial, M.D., and Jonathan Kaufman, M.D., of Winship Cancer Institute; Deborah Berg, M.S.N., Eileen Liao, Ph.D., Alessandra Di Bacco, Ph.D., Jose Estevam, B.Sc., Neeraj Gupta, Ph.D., and Ai-Min Hui, M.D., of Takeda Pharmaceutical International.
Funding for the study was provided by Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceutical International.
About Mayo Clinic Cancer Center
As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 1-855-776-0015 (toll-free).
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, whole-person care to everyone who needs healing. For more information, visit http://www.mayoclinic.org/about-mayo-clinic or http://newsnetwork.mayoclinic.org.
MEDIA CONTACT:
Joe Dangor, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu
iRhythm Technologies, Inc. announced today that study results presented during the American Heart Association (AHA) Scientific Sessions showed an association between a high burden of atrial fibrillation (AFib) and lower cognitive function, specifically executive and verbal function. Previous studies have shown a relationship between AFib, cognitive decline and increased risk of dementia. However, this study, which was led by researchers at the University of Minnesota, demonstrates for the first time a correlation between high AFib burden - the percent of time a person has ...
Amsterdam, NL, 17 November 2014 - Two simple tests conducted during the neurological exam can help clinicians differentiate between early-stage Parkinson's disease (PD) and atypical parkinsonism. By asking patients to perform a tandem gait test and inquiring whether they are still able to ride a bicycle, clinicians can ascertain whether medio-lateral balance is impaired, a defining characteristic of atypical parkinsonism. These findings are published in the Journal of Parkinson's Disease.
This issue of the Journal of Parkinson's Disease also marks the inauguration of ...
Why is Jamaica, with a population smaller than that of Los Angeles, home to so many of the world's elite sprinters - runners who compete in the 100, 200, 400 and 800-meter races?
Robert Trivers, an evolutionary biologist and professor of anthropology and biology in the School of Arts and Sciences, set out with his colleagues to find out if there was something about the symmetry of their knees that might partly explain this phenomenon. They already knew from their earlier research that the symmetry of children's knees at age 8 predicts how fast a person runs 14 years later ...
The sun emitted a mid-level solar flare, peaking at 12:48 p.m. EST on Nov. 16, 2014. NASA's Solar Dynamics Observatory, which watches the sun constantly, captured an image of the event. Solar flares are powerful bursts of radiation. Harmful radiation from a flare cannot pass through Earth's atmosphere to physically affect humans on the ground, however -- when intense enough -- they can disturb the atmosphere in the layer where GPS and communications signals travel.
To see how this event may affect Earth, please visit NOAA's Space Weather Prediction Center at http://spaceweather.gov, ...
Here's another reason to pay close attention to microbes: Current climate models probably overestimate the amount of carbon that will be released from soil into the atmosphere as global temperatures rise, according to research from the US Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab).
The findings are from a new computer model that explores the feedbacks between soil carbon and climate change. It's the first such model to include several physiologically realistic representations of how soil microbes break down organic matter, a process that ...
Fruit flies do not always conform to the norm. When female fruit flies have to decide where to lay their eggs, they take their lead from what they see most others in their group do. However, some do take their personal preferences into account. So says Marine Battesti of the Université Paris-Sud in France, lead author of a study in Springer's journal Behavioral Ecology and Sociobiology.
The site on which an insect chooses to lay her eggs is very important for the development and survival of future generations. Such choices are not fixed, but are influenced by the ...
UC Davis researchers are getting a new look at the workings of HIV and other viruses thanks to new techniques in electron microscopy developed on campus.
The envelope (or Env) protein of HIV is a key target for vaccine makers: it is a key component in RV144, an experimental vaccine that is so far the only candidate to show promise in clinical trials. Also called gp120, the Env protein associates with another protein called gp41 and three gp120/gp41 units associate to form the final trimeric structure. The gp120 trimer is the machine that allows HIV to enter and attack ...
WASHINGTON, Nov. 17, 2014 -- They are seemingly the most popular thing on the Internet, the subject of millions of videos and hundreds of memes: cats. This week Reactions answers some of the biggest kitty questions out there: Why does catnip make most cats go crazy? What does it mean when your cat rubs against your leg? How does kitty litter clump? Check out the nearly purr-fect video here: http://youtu.be/6_C9i-2QGeU.
Subscribe to the series at Reactions YouTube, and follow us on Twitter @ACSreactions to be the first to see our latest videos.
INFORMATION:
The American ...
ABBOTT PARK, Ill., Nov. 17, 2014 - People aged 65 and older, who were being treated for chronic obstructive pulmonary disease (COPD) in the hospital and received nutrition treatment (oral nutrition supplements) had reduced lengths of stay, hospital costs and chances of returning to the hospital within 30-days, according to a study published in CHEST.
Chronic obstructive pulmonary disease (COPD) -- which includes conditions like chronic bronchitis and emphysema -- is a lung disease that compromises breathing. As COPD often occurs among seniors, it is one of the leading ...
Alexandria, Va. -- Hurricane Sandy struck the U.S. East Coast in October 2012, leaving about $65 billion of damage in its wake and raising the question of how to mitigate the damage from future storms. It's a question that arises in the wake of most natural disasters: What steps can society take to protect itself from storms, floods, landslides, earthquakes, tsunamis or volcanic eruptions? But the question itself illustrates the complexity of preparing for natural disasters.
Our first instincts might be to protect ourselves as well as possible, but reality sets in quickly: ...
